X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2590) 2590
Publication (237) 237
Newsletter (80) 80
Book Review (12) 12
Book Chapter (6) 6
Magazine Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1517) 1517
ethanolamines - pharmacology (1441) 1441
male (1264) 1264
humans (1218) 1218
female (755) 755
rats (741) 741
adrenergic beta-antagonists - pharmacology (566) 566
index medicus (551) 551
ethanolamines - therapeutic use (517) 517
nebivolol (512) 512
pharmacology & pharmacy (451) 451
in vitro techniques (421) 421
middle aged (391) 391
adult (381) 381
blood pressure - drug effects (375) 375
dose-response relationship, drug (373) 373
adrenergic beta-agonists - pharmacology (331) 331
isoproterenol - pharmacology (315) 315
heart rate - drug effects (306) 306
adrenergic beta-antagonists - therapeutic use (288) 288
ethanolamines (282) 282
hypertension - drug therapy (279) 279
benzopyrans - therapeutic use (271) 271
mice (264) 264
ethanolamines - metabolism (260) 260
benzopyrans - pharmacology (259) 259
ethanolamines - administration & dosage (252) 252
aged (240) 240
biochemistry & molecular biology (233) 233
guinea pigs (228) 228
propranolol - pharmacology (228) 228
formoterol fumarate (211) 211
time factors (210) 210
propanolamines - pharmacology (204) 204
endocannabinoids (192) 192
kinetics (182) 182
dogs (177) 177
treatment outcome (169) 169
cardiac & cardiovascular systems (154) 154
research (153) 153
rats, wistar (152) 152
hypertension (150) 150
enzyme inhibitors - pharmacology (141) 141
double-blind method (137) 137
rabbits (133) 133
receptors, adrenergic, beta - drug effects (132) 132
ethanolamines - adverse effects (127) 127
anandamide (124) 124
rats, inbred strains (122) 122
norepinephrine - pharmacology (120) 120
rats, sprague-dawley (120) 120
heart - drug effects (119) 119
muscle contraction - drug effects (117) 117
research article (117) 117
cells, cultured (115) 115
neurosciences (114) 114
hemodynamics - drug effects (113) 113
hypertension - physiopathology (113) 113
antihypertensive agents - therapeutic use (112) 112
labetalol - pharmacology (109) 109
nitric oxide (107) 107
adrenergic beta-antagonists - administration & dosage (102) 102
benzopyrans - administration & dosage (99) 99
muscle, smooth - drug effects (99) 99
asthma - drug therapy (97) 97
drug therapy, combination (97) 97
myocardium - metabolism (95) 95
respiratory system (95) 95
palmitic acids - pharmacology (94) 94
labetalol - therapeutic use (93) 93
formoterol (92) 92
stereoisomerism (92) 92
structure-activity relationship (92) 92
drug interactions (90) 90
ethanolamines - chemistry (89) 89
endothelium, vascular - drug effects (88) 88
ethanolamine (88) 88
peripheral vascular disease (87) 87
vasodilator agents - pharmacology (87) 87
nitric oxide - metabolism (86) 86
albuterol - pharmacology (85) 85
myocardial contraction - drug effects (85) 85
vasodilation - drug effects (85) 85
receptors, adrenergic, beta - metabolism (84) 84
adrenergic alpha-antagonists - pharmacology (83) 83
adrenergic beta-antagonists - metabolism (82) 82
receptors, adrenergic, beta - physiology (80) 80
asthma (79) 79
disease models, animal (78) 78
epinephrine - pharmacology (78) 78
nitric-oxide (78) 78
activation (77) 77
lipids (77) 77
antihypertensive agents - pharmacology (76) 76
inflammation (76) 76
adolescent (75) 75
amidohydrolases - antagonists & inhibitors (74) 74
enzymes (74) 74
adrenergic beta-antagonists - adverse effects (73) 73
atenolol (72) 72
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2479) 2479
German (63) 63
Russian (46) 46
Japanese (21) 21
French (19) 19
Italian (19) 19
Polish (7) 7
Spanish (6) 6
Chinese (4) 4
Ukrainian (4) 4
Hungarian (2) 2
Czech (1) 1
Danish (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Pharmacology, ISSN 0007-1188, 03/2013, Volume 168, Issue 6, pp. 1430 - 1444
Background and Purpose Palmitoylethanolamide (PEA) is an endogenous fatty acid amide displaying anti‐inflammatory and analgesic actions. To investigate the... 
intracellular calcium concentrations | PPAR transcription factor | pain | palmitoylethanolamide | transient receptor potential vanilloid type‐1 channels | capsaicin | bradykinin | transient receptor potential vanilloid type-1 channels | N-PALMITOYLETHANOLAMIDE | CA2+ INFLUX | RAT | ROOT GANGLION NEURONS | VR1 RECEPTORS | ANANDAMIDE | HUMAN VANILLOID RECEPTORS | CANNABINOID RECEPTOR | CALCIUM-CHANNELS | PHARMACOLOGY & PHARMACY | CELL-LINE | Ethanolamines - pharmacology | Cricetulus | Endocannabinoids - pharmacology | Membrane Transport Modulators - antagonists & inhibitors | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | TRPV Cation Channels - metabolism | Anti-Inflammatory Agents, Non-Steroidal - antagonists & inhibitors | TRPV Cation Channels - antagonists & inhibitors | Membrane Transport Modulators - pharmacology | Sensory Receptor Cells - metabolism | Palmitic Acids - pharmacology | Action Potentials - drug effects | CHO Cells | Recombinant Proteins - metabolism | Tachyphylaxis | Cell Line | Nerve Tissue Proteins - antagonists & inhibitors | Cricetinae | PPAR alpha - antagonists & inhibitors | Recombinant Proteins - antagonists & inhibitors | Palmitic Acids - antagonists & inhibitors | Nerve Tissue Proteins - agonists | TRPV Cation Channels - agonists | Rats | Ethanolamines - antagonists & inhibitors | Recombinant Proteins - agonists | Nerve Tissue Proteins - genetics | TRPV Cation Channels - genetics | Nerve Tissue Proteins - metabolism | Animals | Sensory Receptor Cells - cytology | Sensory Receptor Cells - drug effects | Drug Antagonism | Calcium Signaling - drug effects | PPAR alpha - agonists | Mice | PPAR alpha - metabolism | Endocannabinoids - antagonists & inhibitors | Research Papers
Journal Article
Journal Article
American Journal of Physiology - Endocrinology And Metabolism, ISSN 0193-1849, 12/2012, Volume 303, Issue 12, pp. 1469 - 1478
The GPR119 receptor plays an important role in the secretion of incretin hormones in response to nutrient consumption. We have studied the ability of an array... 
2-oleoylglycerol | GPR119 | Oleoylethanolamine | Linoleoylethanolamine | GLYCEMIC CONTROL | GUT HORMONES | PHYSIOLOGY | linoleoylethanolamine | ANANDAMIDE | SMALL-INTESTINE | OLEOYLETHANOLAMIDE | DIETARY-FAT INTAKE | oleoylethanolamine | GLUCOSE-HOMEOSTASIS | GLUCAGON-LIKE PEPTIDE-1 | PROTEIN-COUPLED RECEPTOR | ENDOCRINOLOGY & METABOLISM | SECRETION | Endocannabinoids - metabolism | Cannabinoid Receptor Agonists - metabolism | Up-Regulation | Receptors, G-Protein-Coupled - metabolism | Humans | Male | Intestines - metabolism | Receptors, G-Protein-Coupled - agonists | Cannabinoid Receptor Agonists - chemistry | Cannabinoid Receptor Agonists - pharmacology | Thinness - metabolism | Glucagon-Like Peptide 1 - secretion | Oleic Acids - metabolism | Cannabinoid Receptor Antagonists - pharmacology | Fasting - metabolism | Oleic Acids - antagonists & inhibitors | Recombinant Proteins - metabolism | Cell Line | Recombinant Proteins - antagonists & inhibitors | Palmitic Acids - antagonists & inhibitors | Recombinant Proteins - secretion | Mice, Inbred C57BL | Ethanolamines - antagonists & inhibitors | Recombinant Proteins - agonists | Random Allocation | Glycerides - metabolism | Organ Specificity | Endocrine Cells - secretion | Animals | Endocrine Cells - drug effects | Ethanolamines - metabolism | Receptors, G-Protein-Coupled - antagonists & inhibitors | Glycerides - antagonists & inhibitors | Mice | Receptors, G-Protein-Coupled - genetics | Endocannabinoids - antagonists & inhibitors | Palmitic Acids - metabolism | Physiological aspects | Lipids | Cell receptors | Endocannabinoids
Journal Article
Anesthesia and Analgesia, ISSN 0003-2999, 02/2013, Volume 116, Issue 2, pp. 463 - 472
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 08/2005, Volume 7, Issue 5, pp. 710 - 721
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of... 
Heart failure | Isosorbide dinitrate | Beta‐blockers | Digoxin | Angiotensin receptor blockers | Pharmacology | Aldosterone antagonists | Treatment | Eplerenone | Spironolactone | Hydralazine | ACE inhibitors | Clinical recommendations | Beta-blockers | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | treatment | CARDIAC & CARDIOVASCULAR SYSTEMS | angiotensin receptor blockers | QUALITY-OF-CARE | hydralazine | eplerenone | isosorbide dinitrate | RANDOMIZED INTERVENTION TRIAL | beta-blockers | MEDICAL-TREATMENT | GENERAL-PRACTICE | digoxin | spironolactone | CONVERTING-ENZYME-INHIBITORS | clinical recommendations | CARDIAC-INSUFFICIENCY | pharmacology | NATIONAL-SURVEY | aldosterone antagonists | ELDERLY-PATIENTS | Benzopyrans - therapeutic use | Valsartan | Angiotensin Receptor Antagonists | Bisoprolol - therapeutic use | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Valine - administration & dosage | Enalapril - therapeutic use | Ethanolamines - administration & dosage | Indoles - administration & dosage | Ramipril - administration & dosage | Captopril - therapeutic use | Propanolamines - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Ramipril - therapeutic use | Drug Therapy, Combination | Enalapril - administration & dosage | Spironolactone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Lisinopril - administration & dosage | Nebivolol | Valine - analogs & derivatives | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Evidence-Based Medicine | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Bisoprolol - administration & dosage | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Benzopyrans - administration & dosage | Captopril - administration & dosage | Guideline Adherence | Ethanolamines - therapeutic use | Indoles - therapeutic use | Metoprolol - analogs & derivatives | Tetrazoles - therapeutic use | Valine - therapeutic use | Carbazoles - therapeutic use | Propanolamines - administration & dosage | Practice Guidelines as Topic | Prescription writing | Corticosteroids | Isosorbide mononitrate | Family medicine | Nitrates | Peptide hormones | Aldosterone | Preventive health services | Cardiac patients | Angiotensin | Antiandrogens | Medicine, Preventive | Steroids | Kardiologi | converting-enzyme-inhibitors | Cardiac and Cardiovascular Systems | randomized intervention trial | quality-of-care | elderly-patients | cardiac-insufficiency | national-survey | medical-treatment | ventricular systolic dysfunction | general-practice
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 01/2017, Volume 112, Issue Pt A, pp. 144 - 149
Journal Article
Journal Article
Bone, ISSN 8756-3282, 2009, Volume 46, Issue 2, pp. 534 - 542
Journal Article